Bioelectronics Corp (BIEL)

[srinsocal]

There is currently No Way Convertible Lenders can Sell Tens of Billions of Shares into the Market, there is not enough demand for anywhere near that many shares.

KW, PW and Dr Staelin know this.

<<<<<<<< most plausible way they get their loans repaid: R/S and conversion >>>>>>>>

The 2022 EOY Financials estimated 21.557 billion shares would be needed if IBEX Converted all of its $6.032 million in loans. BIEL closed at .0005 on the last Trading day of 2022. BIEL Trading at .005 would only need 2.155 billion shares to cover the same $6 million loan Conversion. But it has to be done organically by growing Sales not with a RS.

The only way KW, PW, and Dr Staelin get their loans paid back is to make BIEL profitable and increase its value by growing Sales.

Reverse Splits without evidence of a company turning itself around quickly find the SP heading back to the pre-RS price. Our friends at Endonovo provided an example of what not to do.

At the end of December 2019, with the SP at .0014 and 1 Billion Shares, ENDV enacted a '1 for 1,000 Reverse Split'.

This raised the SP to $1.40 and lowered the Share count to 1 Million.

It only took 3 months for ENDV's SP to plumet from $1.40 down to 17 cents at the end of March 2020, an 87% drop. ENDV had no positive story to tell.